EMG
CRBP icon

ETF Managers Group’s Corbus Pharmaceuticals CRBP Stock Holding History

ETF Managers Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-157,011
Closed -$777K – 555
2022
Q3 		$777K Sell
157,011
-78,405
-33% -$553K 0.02% 245
2022
Q2 		$1.79M Sell
235,416
-142,017
-38% -$1.37M 0.05% 170
2022
Q1 		$5.79M Sell
377,433
-93,867
-20% -$1.24M 0.12% 132
2021
Q4 		$8.53M Buy
471,300
+1,250
+0.3% +$33.9K 0.17% 137
2021
Q3 		$14.2M Sell
470,050
-343
-0.1% -$13.5K 0.27% 112
2021
Q2 		$26M Buy
470,393
+269,713
+134% +$15M 0.42% 83
2021
Q1 		$11.9M Sell
200,680
-69,441
-26% -$4.56M 0.21% 122
2020
Q4 		$10.1M Buy
270,121
+148,466
+122% +$5.55M 0.22% 110
2020
Q3 		$6.57M Sell
121,655
-1,942
-2% -$352K 0.21% 105
2020
Q2 		$31.1M Buy
123,597
+4,652
+4% +$940K 1.1% 37
2020
Q1 		$18.7M Sell
118,945
-73,710
-38% -$12.5M 0.87% 40
2019
Q4 		$31.6M Sell
192,655
-36,990
-16% -$5.47M 1.1% 36
2019
Q3 		$33.6M Sell
229,645
-4,057
-2% -$707K 1.21% 37
2019
Q2 		$48.6M Buy
+233,702
New +$50M 1.55% 16
2019
Q1 		– Sell
-131,952
Closed -$23.3M – 559
2018
Q4 		$23.3M Buy
+131,952
New +$26.3M 1.1% 24
2018
Q3 		– Sell
-61,015
Closed -$84 – 580
2018
Q2 		$84 Sell
61,015
-20,882
-25% -$3.79M 0.01% 251
2018
Q1 		$14.5M Buy
81,897
+74,308
+979% +$16.7M 0.88% 24
2017
Q4 		$1.81M Buy
+7,589
New +$1.62M 0.13% 89

Other funds holding CRBP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ETF Managers Group's CRBP Position: Q4 2022 in Review

ETF Managers Group sold out of Corbus Pharmaceuticals (CRBP) in Q4 2022, closing a stake of 157,011 shares — an estimated $777K sold.

ETF Managers Group first reported a position in CRBP in Q4 2017 and held it in 18 quarters. The position peaked at $48.6M in Q2 2019. 63 funds tracked by Wall St. Rank hold CRBP as of Q4 2022.

  • ETF Managers Group reported no remaining Corbus Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • ETF Managers Group sold 157,011 Corbus Pharmaceuticals shares in Q4 2022, an estimated $777K.
  • ETF Managers Group first reported a position in Corbus Pharmaceuticals in Q4 2017 and held it in 18 quarters.
  • ETF Managers Group's Corbus Pharmaceuticals position peaked at $48.6M in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2022.

Based on ETF Managers Group's 13F filing for Q4 2022, filed 23 Mar 2023.